Amyn A Habib

9PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Preventative health careCell development, proliferation and deathMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 08, 2026
EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma.

|May 20, 2026
Multifaceted roles of PDS5B in RAD51-dependent homology-directed DNA repair and replication fork protection.

|Sep 11, 2024
Promotion of DNA end resection by BRCA1-BARD1 in homologous recombination.

Sameer Salunkhe, James M Daley, Hardeep Kaur

|Aug 01, 2022
EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation.

Gao Guo, Ke Gong, Nicole Beckley

|Dec 02, 2021
Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids.

Ke Gong, Gao Guo, Nicole A Beckley

|Dec 03, 2020
EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer.

Ke Gong, Gao Guo, Nishah Panchani

Pageof 2

Frequent Collaborators

5 joint publications

Sandeep Burma

3 joint publications

Dawen Zhao

2 joint publications

Chao Xing

2 joint publications

David S Libich